| 254 |
220: Increase, Plasma vitellogenin concentrations |
252: Increase, Renal pathology due to VTG deposition |
Nov 29, 2016 |
Jun 24, 2024 |
2 AOPs
|
| 255 |
221: Reduction, Plasma vitellogenin concentrations |
309: Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development |
Nov 29, 2016 |
Mar 20, 2017 |
9 AOPs
|
| 257 |
231: Decreased, PPAR-alpha activation |
140: Decreased, HSD17B10 expression |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 259 |
232: Decreased, PPAR-beta activation |
140: Decreased, HSD17B10 expression |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 260 |
233: Decreased, PPAR-gamma activation |
140: Decreased, HSD17B10 expression |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 229 |
201: Binding of antagonist, NMDA receptors |
195: Inhibition, NMDARs |
Nov 29, 2016 |
Jun 13, 2018 |
2 AOPs
|
| 262 |
238: Induction, Pre-mature molting |
350: Increase, Mortality |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 263 |
238: Induction, Pre-mature molting |
351: Increased Mortality |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 266 |
240: Feminisation or incomplete development, Primary and accessory male sex organs |
337: N/A, Impairment of reproductive capacity |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 268 |
243: Reduction, Prostaglandin E2 concentration |
119: N/A, Gap |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 269 |
244: Alkylation, Protein |
55: Cell injury/death |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 271 |
244: Alkylation, Protein |
209: Peptide Oxidation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 272 |
246: Increase, RBC congestion in liver |
173: N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 277 |
250: Damaging, Red blood cells; hemolysis |
161: Increase, Liver and splenic hemosiderosis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 278 |
250: Damaging, Red blood cells; hemolysis |
173: N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 279 |
250: Damaging, Red blood cells; hemolysis |
246: Increase, RBC congestion in liver |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 280 |
252: Increase, Renal pathology due to VTG deposition |
339: Altered, Larval development |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 359 |
386: Neuronal network function, Decreased |
341: Impairment, Learning and memory |
Nov 29, 2016 |
Jul 15, 2022 |
6 AOPs
|
| 360 |
387: Binding of agonist, NMDARs |
388: Overactivation, NMDARs |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 361 |
388: Overactivation, NMDARs |
389: Increased, Intracellular Calcium overload |
Nov 29, 2016 |
Sep 10, 2023 |
4 AOPs
|
| 362 |
389: Increased, Intracellular Calcium overload |
177: Increase, Mitochondrial dysfunction |
Nov 29, 2016 |
Nov 29, 2016 |
2 AOPs
|
| 363 |
177: Increase, Mitochondrial dysfunction |
55: Cell injury/death |
Nov 29, 2016 |
Nov 29, 2016 |
4 AOPs
|
| 364 |
55: Cell injury/death |
352: N/A, Neurodegeneration |
Nov 29, 2016 |
Sep 10, 2023 |
2 AOPs
|
| 365 |
55: Cell injury/death |
188: Neuroinflammation |
Nov 29, 2016 |
Jul 15, 2022 |
3 AOPs
|
| 392 |
219: Reduction, Plasma 17beta-estradiol concentrations |
405: disrupted, ovarian cycle |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|